Citation Impact

Citing Papers

Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
2012 StandoutScience
Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus
2009 StandoutNobel
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
Effective treatment of severe COVID-19 patients with tocilizumab
2020 Standout
Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters
2010
Id Proteins
2014
2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient Cohorts
2016 Standout
MicroRNA-21 and MicroRNA-148a Contribute to DNA Hypomethylation in Lupus CD4+ T Cells by Directly and Indirectly Targeting DNA Methyltransferase 1
2010
Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis
2018 StandoutNobel
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 Standout
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Neutrophils Regulate Humoral Autoimmunity by Restricting Interferon-γ Production via the Generation of Reactive Oxygen Species
2015
Shared and distinct mechanisms of fibrosis
2019
Tregopathies: Monogenic diseases resulting in regulatory T-cell deficiency
2018
Atopic Dermatitis
2008 Standout
Heterozygous Mutations in TREX1 Cause Familial Chilblain Lupus and Dominant Aicardi-Goutières Syndrome
2007 StandoutNobel
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Cutting it close: CRISPR-associated endoribonuclease structure and function
2014 StandoutNobel
Type I interferons in Sjögren's syndrome
2012
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
2010 Standout
Genome-wide association studies in Sjögren's syndrome: What do the genes tell us about disease pathogenesis?
2014
Rheumatoid arthritis
2016 Standout
Type I interferon blockade in systemic lupus erythematosus: where do we stand?
2013
Development of TLR inhibitors for the treatment of autoimmune diseases
2008
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
2013
Association of Schizophrenia and Autoimmune Diseases: Linkage of Danish National Registers
2006
Emerging role of extracellular vesicles in inflammatory diseases
2014
Crosstalk between fibroblasts and inflammatory cells
2014
Juvenile idiopathic arthritis
2007 Standout
2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome
2016 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Pattern Recognition Receptors and Inflammation
2010 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Pregnancy Outcomes in Patients with Autoimmune Diseases and Anti-Ro/SSA Antibodies
2009
The role of microparticles in the pathogenesis of rheumatic diseases
2009
Chitinases in the salivary glands and circulation of patients with Sjögren's syndrome: Macrophage harbingers of disease severity
2011
Innate immune functions of plasmacytoid dendritic cells
2006
Neutrophils in the activation and regulation of innate and adaptive immunity
2011 Standout
The cryoglobulinaemias
2011
Primary Sjogren's syndrome: too dry and too tired
2010
Sensors of the innate immune system: their link to rheumatic diseases
2010 StandoutNobel
TFOS DEWS II Epidemiology Report
2017 Standout
A trio of microRNAs that control Toll-like receptor signalling
2011
A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti–Jo‐1 or anti–Ro 52/anti–Ro 60 autoantibodies
2007
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
How the study of children with rheumatic diseases identified interferon‐α and interleukin‐1 as novel therapeutic targets
2008
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
2014
Neutrophil extracellular traps in immunity and disease
2017 Standout
Type I interferons: crucial participants in disease amplification in autoimmunity
2010
Type I Interferon in Systemic Lupus Erythematosus and Other Autoimmune Diseases
2006
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo‐phase trial
2012
Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21
2009
Systemic Lupus Erythematosus
2011 Standout
Dendritic cell subsets in health and disease
2007
Systemic amyloidosis
2015 Standout
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Serological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritis
2012
Physiological and pathological roles for microRNAs in the immune system
2010 Nobel
Enhanced Activation of Memory, but Not Naïve, B Cells in Chronic Hepatitis C Virus-Infected Patients with Cryoglobulinemia and Advanced Liver Fibrosis
2013 StandoutNobel
Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies
2015
Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infections
2014
Macrophage plasticity and polarization: in vivo veritas
2012 Standout
Regulation of type I interferon responses
2013 Standout
Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets
2016 Standout
Potential approaches to reverse or repair renal fibrosis
2014
Dendritic cells – why can they help and hurt us
2009
Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis
2010
Epigenetic modifications and human disease
2010 Standout
Evaluation and Management of the Cardiac Amyloidosis
2007
Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication
2018 Standout
Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature Review
2015
Flow cytometric analysis of circulating microparticles in plasma
2010
Cutaneous Dermatomyositis: An Updated Review of Treatment Options and Internal Associations
2013
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Microparticles: Key Protagonists in Cardiovascular Disorders
2010
Idiopathic Inflammatory Myopathies: Current Trends in Pathogenesis, Clinical Features, and Up-to-Date Treatment Recommendations
2012
Trex1 Exonuclease Degrades ssDNA to Prevent Chronic Checkpoint Activation and Autoimmune Disease
2007 StandoutNobel
Extracellular vesicles: Exosomes, microvesicles, and friends
2013 Standout
Exosomes
2019 Standout
Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes
2016 Standout
Inflammatory Muscle Diseases
2015 Standout
Regulatory T Cells and Human Disease
2020 StandoutNobel
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing
2009 StandoutNobel
Cytosolic DNA sensors regulating type I interferon induction
2011
Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by Zap70 Mutation
2019 StandoutNobel
The Ratio of Blood T Follicular Regulatory Cells to T Follicular Helper Cells Marks Ectopic Lymphoid Structure Formation While Activated Follicular Helper T Cells Indicate Disease Activity in Primary Sjögren's Syndrome
2018
Platelet microvesicles in health and disease
2017
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
An RNA Element in Human Interleukin 6 Confers Escape from Degradation by the Gammaherpesvirus SOX Protein
2013
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Tocilizumab in rheumatoid arthritis: A meta-analysis of efficacy and selected clinical conundrums
2013

Works of Jacques‐Eric Gottenberg being referenced

Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren’s syndrome
2006
Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome
2015
Bruton’s Tyrosine Kinase Is Involved in miR-346-Related Regulation of IL-18 Release by Lipopolysaccharide-Activated Rheumatoid Fibroblast-Like Synoviocytes
2009
B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis
2013
Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry
2010
Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity
2009
Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features
2006
Safety and Efficacy of Rituximab in Severe Juvenile Dermatomyositis: Results from 9 Patients from the French Autoimmunity and Rituximab Registry
2011
No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome
2006
Is Inhibitor of differentiation 3 involved in human primary Sjögren's syndrome?
2008
Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: Data from the French Autoimmunity and Rituximab registry
2010
miR-346 Controls Release of TNF-α Protein and Stability of Its mRNA in Rheumatoid Arthritis via Tristetraprolin Stabilization
2011
Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR‐ and type‐I IFN‐dependent and ‐independent pathways
2008
EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome
2009
Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries
2010
Abatacept therapy and safety management
2009
Rituximab Treatment for Spondyloarthritis. A Nationwide Series: Data from the AIR Registry of the French Society of Rheumatology
2012
Anti–tumor necrosis factor α therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: A followup report of tolerability and efficacy
2003
Microparticle-induced release of B-lymphocyte regulators by rheumatoid synoviocytes
2009
In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response
2003
Tocilizumab: Therapy and safety management
2010
Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome
2014
The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome
2009
Efficacy and safety of rituximab for systemic lupus erythematosus‐associated immune cytopenias: A multicenter retrospective cohort study of 71 adults
2017
Safety of Surgery After Rituximab Therapy in 133 Patients With Rheumatoid Arthritis: Data From the AutoImmunity and Rituximab Registry
2013
Rankless by CCL
2026